Skip to content

ABOUT US

WHO ARE WE
Pharmecons is an international outcomes research agency specializing in market access issues, health economics and patient-reported outcomes (PRO). We are based in the UK, with academic links around Europe, particularly the University of York, UK and the largest universities in Greece, which allow us to draw on emergent research in health economics, evidence based medicine, patient reported outcomes and market access portfolio.

We have extensive experience in building Markov and other decision-analytic models, discrete choice experiments, utility elicitation and other health technology assessment tools. We are experts in writing reports for reimbursement authorities, building value dossiers for the broader health-care community and communication plan with specific key messages, objection handlers and flashcards to help you elevate your research. We have a great network of international researchers such as health economists, outcomes researchers, clinical and regulatory specialists based in the UK, and Greece.
EXPERTISE
  • Decision modelling
  • Evidence review and synthesis, including standard and network meta-analysis for Health Technology Assessment
  • Design of economic evaluations alongside clinical trials
  • Analysis of individual patient –level data from randomized clinical trials
  • Elicitation of value judgements (Discrete choice experiments, Best worst scaling )
  • Utility elicitation
  • Real World Evidence studies
MEET THE TEAM

Eugena Stamuli, MSc

Health Economics & Outcomes/Preferences Research (HEOR) Director
Founding Partner

eugena.stamuli@pharmecons.com

Bio

Eugena Stamuli holds an MSc in Health Economics and Management from University of Sheffield, UK and a BSc in Pharmacy from University of Athens, Greece. Her passion has always been the marrying of pharmacy and economics, hence she pursued a career in Health Economics. Eugena holds a Visiting Research Fellowship position with University of York, UK where she worked for nearly 10 years prior to establishing PharmEcons Easy Access. Eugena has also gained extensive experience in health economics consultancy environment. She has conducted numerous primary studies and analyses in various disease areas. Her areas of expertise include cost-effectiveness modelling/early modelling, design and conduct of economic evaluations alongside clinical trials, discrete choice experiments, utility elicitation and evidence review & synthesis.

Magda Chatzikou, PhD

Market Access Director
Founding Partner

magda.chatzikou@pharmecons.com

Bio

Magda Chatzikou holds a PhD by University of Thessaly in health economics with an 18 year experience in the pharmaceutical industry. She is currently adjunct faculty at Open University of Greece at post graduate course of Health Care Management. She has served many roles in market access departments of the multinational industry emphasizing on pricing, reimbursement and health economics. Magda can be considered as the “linking chain” between clinical research and commercial value. She has worked in various therapeutic areas such as cancer, haematological disorders, diabetes, hypertension, COPD, autoimmune diseases and biosimilars. After 18 years in the industry, she decided to continue with her profession from a different perspective always linked with the pharmaceutical industry.

Michael Kerr, PhD

Social Scientist

micky.kerr@pharmecons.com

Bio

Micky Kerr is occupational psychologist from University of Sheffield. Micky is the director of Pharmecons Easy Access and in parallel is the leader of qualitative research to investigate apprenticeship programmes at Sheffield Hallam University. He is responsible for the design, conduction and management of the research across a range of sectors including healthcare, digital and engineering. He has collaborated with the National Institute for Health Research, Biomedical Research Centre, University of Nottingham by undertaking qualitative analyses of data collected concerning tinnitus constructs, and their meaning to patients and professionals. It has contributed to The Core Outcome Measures in Tinnitus (COMiT) initiative to develop standards for outcome measures in clinical trials. Micky was a research fellow at Barnsley Hospital, NHS Foundation Trust with a multi-disciplinary research team to develop, design, conduct, and manage research into the provision of assistive technologies; and telecare/health equipment.

Dimitra Latsou, PhD

Social Sciences
& Biostatistics Associate

demi.latsou@pharmecons.com

Bio

Dimitra Latsou is a graduate of Political Science and Public Administration from the University of Athens, Greece. She completed the postgraduate program in Management and Economic Evaluation of Professional and Environmental Health, at the Medical School of the University of Athens. She holds a PhD from the University of Peloponnese in the scientific field: Economic Analysis of Social Policies. Dimitra has more than 12 years of experience in the field of social policy, patient reported outcomes, patient reported experience studies and economic analysis in health issues.

Declan O' Byrne, PhD

Health Economics Associate

declan.obyrne@pharmecons.com

Bio

Declan O Byrne is a health scientist with a MSc in health economics and health policy from Birmingham university and a PhD in Immunology by Bath university. Declan is an experienced project manager in the field of decision analysis, modelling and biostatistics. He has worked as research associate at ScHARR in the analysis of clinical trial data.

BUSINESS CERTIFICATIONS